Thursday, 4 December 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 04 December 2025
News

MS cases and costs skyrocket

Posted 3 December 2025 PM

The number of Australians living with multiple sclerosis (MS) has risen by more than 13 per cent in just three years, driving the cost of the disease to more than $3 billion a year, a new report has found.

A record 37,756 Australians were living with MS last year, according to the report, Multiple Sclerosis Prevalence and Health Economic Impact in Australia 2025, commissioned by MS Australia and produced in collaboration with the Menzies Institute for Medical Research at the University of Tasmania.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (17)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (3)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.